Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences/Roche, SOLiDApplied Biosystems and Solexa/Illumina Inc..
The three companies each have agreed to sequence the equivalent of 75 billion DNA bases in the program’s pilot phase, generating the equivalent of 25 human genomes each over the coming year, according to GenomeWeb.
Update: There is a nice piece on this over at the Genetic Future blog
Abstract
With Next Generation Sequencing (NGS) technologies, High Throughput Sequencing has become accessible to a much larger group of researchers. NGS technologies therefore have the potential to transform biomedical research and eventually also health care areas such as molecular diagnostics and personalized medicine.
However, High Throughput Analysis has not become commonly accessible yet, and therefore data analyses represents a serious bottleneck, which prevents scientists from reaching the full potential of the NGS technologies.
In these sessions, I will give you our perspective on the bioinformatics challenges arising from NGS data and how we are addressing these to make High Throughput Analysis accessible for all researchers. The session will include a presentation of the CLC Genomics Workbench software.
June 5th • Singapore
Thursday at 3:30 PM
Aspiration Theatre
Biopolis
June 6th • Kuala Lumpur
Friday at 3 PM
University of Malaya
Institute of Biological Sciences
Free access for all. Sign up by sending an e-mail with your name and organization to ngs@clcbio.com
